Australia markets closed

Shattuck Labs, Inc. (STTK)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
10.78-0.32 (-2.88%)
At close: 04:00PM EDT
10.78 0.00 (0.00%)
After hours: 04:00PM EDT

Shattuck Labs, Inc.

500 West 5th Street
Suite 1200
Austin, TX 78701
United States
512 900 4690
https://www.shattucklabs.com

Sector(s)Healthcare
IndustryBiotechnology
Full-time employees75

Key executives

NameTitlePayExercisedYear born
Dr. Taylor H. Schreiber M.D., Ph.D.Co-Founder, CEO & Director792.88kN/A1980
Mr. Andrew R. Neill M.B.A.Chief Financial Officer603.96kN/A1986
Dr. Arunthathy Nirmalini Pandite M.B.A., M.D.Chief Medical Officer695.24kN/A1959
Dr. Abhinav A. Shukla Ph.D.Chief Technical Officer567.4kN/A1973
Mr. Conor Richardson CPAVice President of Investor RelationsN/AN/AN/A
Dr. Stephen Stout J.D., Ph.D.General Counsel, Corporate Secretary and Chief Ethics & Compliance OfficerN/AN/A1975
Ms. Casi DeYoungChief Business Officer523.48kN/A1971
Dr. Thomas Lampkin Pharm.D.Senior Vice President of Regulatory AffairsN/AN/AN/A
Mr. George Fromm Ph.D.Chief Scientific Officer of ARC PlatformN/AN/AN/A
Mr. Suresh de Silva Ph.D.Chief Scientific Officer of GADLEN PlatformN/AN/AN/A
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. Shattuck Labs, Inc. was incorporated in 2016 and is headquartered in Austin, Texas.

Corporate governance

Shattuck Labs, Inc.’s ISS governance QualityScore as of 1 May 2024 is 6. The pillar scores are Audit: 4; Board: 6; Shareholder rights: 8; Compensation: 7.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.